Company Overview
Product
Research & Development
Investor Relations
Company Overview
Product
Research & Development
Investor Relations
Last updated --
| Category | Project Title | Indication | Discovery | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | NDA | Market |
|---|---|---|---|---|---|---|---|---|---|
| New Molecular Entity |
HN01001 | Erosive esophagitis |
|
||||||
| BOLD-100 | Colorectal Cancer |
|
|||||||
| HN61001 | General anesthesia |
|
|||||||
| Incrementally Modified Drug |
HN43001 | Peptic ulcer |
|
||||||
| HN53011 | General anesthesia |
|
|||||||
Last updated --
| Category | Project Title | Indication | Process Development | Process Validation | NDA | Market |
|---|---|---|---|---|---|---|
| API | HNP-2007 | General anesthesia |
|
|||
| HN01001 | Erosive esophagitis |
|
||||